Baumgart, Daniel C.
Stallmach, Andreas
Grunert, Philip
Schubert, Stefan
Howaldt, Stefanie
von Arnim, Ulrike
Ochsenkühn, Thomas
Stein, Jürgen
Lügering, Andreas
Schmidt, Daniel
Schulz, Marten
Fischer, Andreas
Article History
Received: 6 June 2024
Accepted: 14 August 2024
First Online: 3 September 2024
Competing interests
: D.C.B. has over the past five years served on scientific advisory boards, speaker or moderator at CME events for, and/or received travel support from Janssen-Cilag, AbbVie, Pfizer, BMS, Falk Foundation, Takeda, Eli Lilly, Tillotts Pharma AG, and Galapagos. J.S. has received consulting fees from Abbvie, Bristol Myers Squibb, Dr Schär, Falk, Ferring, Fresenius Kabi, Immundiagnostik, Janssen, Medice, MSD, Pfizer, Pharmacosmos, Shire, Takeda, Thermofisher, Vifor, lecturing fees from Vifor Pharma, and is an Advisory Board member for Abbvie, Bristol Myers Squibb, Dr Schär, Ferring, Fresenius Kabi, Immundiagnostik, Janssen, MSD, NPS, Pharmacosmos, Takeda, Vifor and Shield. T.O. was the recipient of an unrestricted research grant from Biogen, Germany. Over the past five years T.O. has served on scientific advisory boards, and/or served as speaker or moderator at conferences and CME events for, and/or received travel support from, AbbVie, Amgen, Biogen, BMS, Celltrion, Janssen-Cilag, Lilly, MSD, Pfizer, Sandoz, Takeda, Tillots, Viatris and Vifor. A.L. has served on scientific advisory boards, and/or served as speaker or moderator for AbbVie, Biogen, BMS, Falk Foundation, Ferring, Hexal, Janssen, MSD, Nutrimmun, Pfizer, Takeda, and Tillotts Pharma. AS reports research funding from AbbVie and Celltrion. He has received lecture fees from AbbVie, Amgen, Astellas, Biogen, Celltrion, Janssen, Falk Foundation, Ferring, MSD, Recordati Pharma, Streamed-Up and Takeda and consulting fees from AbbVie, Astellas, Amgen, Biogen, CLS Behring, Consal, Eli Lilly, Galapagos, Hexal, Janssen, MSD, Norgine, Pfizer Pharma Takeda and Tillots Pharma. S.H. has received consulting and lecturing fees and has served on scientific advisory boards from Abbvie, Bristol Myers Squibb, Eli Lilly, Fresenius Kabi, Janssen, Galapagos, Pfizer, Pharmacosmos, Shield, Takeda. U.v.A. has received consulting and lecturing fees from Abbvie, Bristol Myers Squibb,EsoCap, Falk Foundation, Janssen, MSD, Pfizer, Pharmacosmos, Sanofi, Takeda, ViforPharma, and is an Advisory Board member for Abbvie, Bristol Myers Squibb, Janssen, MSD, Pharmacosmos, Takeda, Vifor , Pfizer and Sanofi. D.S., P.G. and A.F. declare no conflict of interest.